Last reviewed · How we verify
NCT04610762
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
trial testing GeneXpert HCV VL Fingerstick test in Hepatitis C, Chronic in 103 participants. Completed in 17 November 2022.
17 November 2021
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire Saint Pierre |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 103 |
| Start date | 17 November 2020 |
| Primary completion | 17 November 2021 |
| Estimated completion | 17 November 2022 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- GeneXpert HCV VL Fingerstick test
Conditions studied
- Hepatitis C, Chronic — all drugs for Hepatitis C, Chronic →
Sponsor
Centre Hospitalier Universitaire Saint Pierre
Who can join
18 and older, any sex, with Hepatitis C, Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to assess the interest (linkage to care) of the Cepheid GeneXpert HCV VL Fingerstick test in Brussels among drug users or former users in contact with the Réseau Hépatite C Bruxelles organization through different partners of this network.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04610762
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatitis C, Chronic
Currently open trials in the same condition.
- NCT04014179 — Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs · NA · active not recruiting
- NCT04943588 — Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs · recruiting
- NCT03520660 — People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents · Phase 4 · active not recruiting
- NCT03200379 — Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan · recruiting
Other Centre Hospitalier Universitaire Saint Pierre trials
Trials by the same sponsor.
- NCT06814600 — Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients · recruiting
- NCT06214312 — Pulmonary Ultrasound for the Assessment of Atelectasis in Anesthetized Children Using a Laryngeal Mask Airway. · completed
- NCT05856396 — Maternal Determinants of Infant Immunity to Pertussis · Phase 4 · completed
- NCT05898737 — Nociception Level Index (NOL Index) for Obstetrical Pain Assessment Under Epidural Analgesia. · unknown
- NCT05848531 — Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04610762 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Saint Pierre
- Last refreshed: 6 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04610762.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing